Michael Fried
Impact in
- Hepatology top 0.01%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Gastroenterology top 0.05%
- Gastrointestinal motility and disorders
- Gastroesophageal reflux and treatments
Papers in
- Hepatology 210
- Hepatitis C virus research 189
- Liver Disease and Transplantation 26
-
- Gastrointestinal motility and disorders 44
- Gastroesophageal reflux and treatments 43
- Co-authors
- Antonio Craxı̀ (7 shared papers)K. Rajender Reddy (38 shared papers)Mitchell L. Shiffman (16 shared papers)Werner Schwizer (87 shared papers)Coleman I. Smith (7 shared papers)Dieter Häussinger (3 shared papers)Fernando Lopes Gonçales (3 shared papers)M. Diago (4 shared papers)
- Journals
- Gastroenterology (55 papers)Journal of Hepatology (38 papers)Hepatology (35 papers)Digestive Diseases and Sciences (20 papers)Alimentary Pharmacology & Therapeutics (20 papers)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Michael Fried
478 papers receiving 32.9k citations
Michael Fried's Hit Papers
Peers
Comparison fields: 5 of 199
- Hepatology 20.4k
- Gastroenterology 3.2k
- Epidemiology 14.5k
- Infectious Diseases 2.6k
- Pharmacology 979
Countries citing papers authored by Michael Fried
This map shows the geographic impact of Michael Fried's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Fried with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Fried more than expected).
Fields of papers citing papers by Michael Fried
This network shows the impact of papers produced by Michael Fried. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Fried. The network helps show where Michael Fried may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Fried, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 505 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection Hit paper breakdown → | 2002 | 5458 |
| 2 | Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B Hit paper breakdown → | 2005 | 1253 |
| 3 | Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis Hit paper breakdown → | 2014 | 981 |
| 4 | EASL Clinical Practice Guidelines: Management of hepatitis C virus infection European Association for the Study of the Liver ⇑ Hit paper breakdown → | 2013 | 877 |
| 5 | A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness Hit paper breakdown → | 2000 | 806 |
| 6 | Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease Hit paper breakdown → | 2015 | 681 |
| 7 | Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis Hit paper breakdown → | 2015 | 658 |
| 8 | Side effects of therapy of hepatitis C and their management Hit paper breakdown → | 2002 | 619 |
| 9 | Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection Hit paper breakdown → | 2011 | 605 |
| 10 | Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection Hit paper breakdown → | 2017 | 569 |
| 11 | Hepatic Failure and Lactic Acidosis Due to Fialuridine (FIAU), an Investigational Nucleoside Analogue for Chronic Hepatitis B Hit paper breakdown → | 1995 | 514 |
| 12 | 2002 | 493 | |
| 13 | 2005 | 425 | |
| 14 | 2006 | 406 | |
| 15 | 2004 | 394 | |
| 16 | 2014 | 375 | |
| 17 | 2001 | 307 | |
| 18 | 1995 | 285 | |
| 19 | 1992 | 251 | |
| 20 | 2016 | 249 |
About Michael Fried
Michael Fried is a scholar working on Hepatology, Gastroenterology, Epidemiology, Surgery and Infectious Diseases, having authored 505 papers that have together received 34.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (189 papers), Liver Disease Diagnosis and Treatment (87 papers), Hepatitis B Virus Studies (73 papers), Gastrointestinal motility and disorders (44 papers), Gastroesophageal reflux and treatments (43 papers), Liver Disease and Transplantation (26 papers), Helicobacter pylori-related gastroenterology studies (24 papers) and Diet and metabolism studies (21 papers). The work is most often cited by research in Hepatology (20.4k citations), Gastroenterology (3.2k citations), Epidemiology (14.5k citations), Infectious Diseases (2.6k citations) and Pharmacology (979 citations). Michael Fried has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Antonio Craxı̀, K. Rajender Reddy, Mitchell L. Shiffman, Werner Schwizer, Coleman I. Smith, Dieter Häussinger, Fernando Lopes Gonçales, M. Diago, Daniel Dhumeaux and George Marinos. Their work appears in journals such as Gastroenterology, Journal of Hepatology, Hepatology, Digestive Diseases and Sciences and Alimentary Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.